Issue 6/2013
Content (19 Articles)
Channeling health economics research initiatives to improve decision-making processes in the EU
F. Antonanzas, R. Rodríguez-Ibeas
Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease
Monia Marchetti, Nicola L. Liberato, Antonio Di Sabatino, Gino R. Corazza
The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice
Ingrid Lekander, Fredrik Borgström, Jörgen Lysholm, Ronald F. van Vollenhoven, Staffan Lindblad, Pierre Geborek, Gisela Kobelt
Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
P. A. Laires, F. Exposto, R. Mesquita, A. P. Martins, L. Cunha-Miranda, J. E. Fonseca
The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies
Jen Kruger, Alan Brennan
Internal validation of models with several interventions
Afschin Gandjour, Amiram Gafni
Quantifying short run cost-effectiveness during a gradual implementation process
Gijs van de Wetering, Willem H. Woertman, Andre L. Verbeek, Mireille J. Broeders, Eddy M. M. Adang
Explaining length of stay variation of episodes of care in the Netherlands
Siok Swan Tan, Leona Hakkaart-van Roijen, B. Martin van Ineveld, W. Ken Redekop
Managing for efficiency in health care: the case of Greek public hospitals
Panagiotis Mitropoulos, Ioannis Mitropoulos, Aris Sissouras
Treatment costs of attention deficit hyperactivity disorder in Germany
Sebastian Braun, Jan Zeidler, Roland Linder, Susanne Engel, Frank Verheyen, Wolfgang Greiner
Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information
Leyla Mohseninejad, Talitha Feenstra, Henriëtte E. van der Horst, Hèlen Woutersen-Koch, Erik Buskens
The impact of generic reference pricing in Italy, a decade on
Simone Ghislandi, Patrizio Armeni, Claudio Jommi
Maximal endurable time states and the standard gamble: more preference reversals
P. F. M. Stalmeier, A. L. Verheijen
How efficient are Greek hospitals? A case study using a double bootstrap DEA approach
Kostas Kounetas, Fotis Papathanassopoulos
Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children
Peter Kiencke, Kristina Viehmann, Reinhard Rychlik
Long-term health investment when people underestimate their adaptation to old age-related health problems
Octave Jokung, Serge Macé
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany
Bernhard Ultsch, Ingrid Köster, Thomas Reinhold, Anette Siedler, Gérard Krause, Andrea Icks, Ingrid Schubert, Ole Wichmann
TIPP and Lichtenstein modalities for inguinal hernia repair: a cost minimisation analysis alongside a randomised trial
G. G. Koning, E. M. M. Adang, P. F. M. Stalmeier, F. Keus, P. W. H. E. Vriens, C. J. H. M. van Laarhoven
Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation
Björn Stollenwerk, Afschin Gandjour, Markus Lüngen, Uwe Siebert